Our previous studies using a selection from a combinatorial random peptide library against breast and pancreatic cancer cell lines identified several peptides [20] mimicking neuroligin (NLGN-1, 3 and NLGN4X). This evidence concerns the gene NLGN4X and pancreatic neoplasm.